← FDA Drug Approvals (Drugs@FDA)
RUZURGI
NDA · New Drug Application · Sponsor: JACOBUS PHARM CO INC · Approved 2022-02-01
Drug application
- FDA Application #
NDA209321- Application type
- New Drug Application
- Brand name
- RUZURGI
- Generic name
- Amifampridine
- Active ingredients
- AMIFAMPRIDINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- JACOBUS PHARM CO INC
- First approval
- 2022-02-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown